Titan International, Inc.
NYSE:TWIAgricultural - Machinery
+$0.24 today
- Market cap
- $283.62M
- Beta
- 1.47
- P/E (TTM)
- -5.6
- EPS (TTM)
- -$1.36
Volume 0.77M
Average 0.93M
TWI Income Tax Expense
Income taxes recognized for the period, including current and deferred tax.
Titan International, Inc.NYSE: TWI
Income Tax Expense · Q1 FY2026 · quarter ended Mar 2026
Income tax expense grows, but more slowly than its trailing trend
Q1 FY2026 income tax expense of $4.63M rose 9.5% year over year, behind the +691.4% change in trailing-twelve-month income tax expense. Sequentially, it fell 88.4% from the prior quarter. Over 3 fiscal years it compounded at +29.1% a year.
Context
- Income tax expense amounted to 2.7% of revenue in FY2025, up 2.1 pp from a year earlier.
- Income tax expense increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +9.5% toward the trailing-twelve-month pace of +691.4%.
Sources:Income StatementText generated from reported figures; not investment advice.
Income Tax Expense history
USD · from the income statement
- Latest · FY2025
- 49.89M USD
- Year-over-year change
- +320.6%
- 4-year CAGR
- +156.7%
| Period | Period end | Income Tax Expense | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 49.89M | +320.6% |
| FY2024 | 2024-12-31 | 11.86M | -54.5% |
| FY2023 | 2023-12-31 | 26.04M | +12.4% |
| FY2022 | 2022-12-31 | 23.17M | +1916.3% |
| FY2021 | 2021-12-31 | 1.15M | — |
Income Tax Expense vs competitors
How TWI compares with its peers on the latest reported figures
- TWI's LTM Mar 2026 income tax expense of $50.29M is the highest of the 11 companies compared; the peer median is $2.63M.
- Its year-over-year change of +691.4% is the 2nd highest of 10, against a peer median of +71.1%.
- Income tax expense amounts to 2.7% of revenue for TWI, versus a peer median of 0.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $50.29M | +691.4% | +29.1% | 2.7% | |
| LTM Mar 2026 | $22.93M | +6348.0% | -4.2% | 1.9% | |
| LTM Mar 2026 | $17M | +142.9% | +47.4% | 1.6% | |
| LTM Mar 2026 | $5.11M | -39.9% | — | 5.8% | |
| LTM Mar 2026 | $4.4M | +109.1% | +15.2% | 0.2% | |
| LTM Mar 2026 | $3.58M | -90.3% | -68.2% | 0.2% | |
| LTM Mar 2026 | $1.67M | +71.1% | +2.2% | 0.9% | |
| LTM Mar 2026 | $861K | -92.6% | -67.6% | 0.1% | |
| LTM Mar 2026 | $270K | +67.7% | +5.2% | 0.1% | |
SRTAStrata Critical Medical, Inc. | LTM Mar 2026 | $21K | +111.2% | — | 0.0% |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding TWI) | $2.63M | +71.1% | +2.2% | 0.2% | |
Competitors are the stored peer set for TWI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.78B | 2.17B | 1.82B | 1.85B | 1.83B |
| Cost of Revenue | 1.54B | 1.81B | 1.52B | 1.59B | 1.59B |
| Gross Profit | 237.54M | 360.71M | 305.85M | 257.8M | 242.35M |
| Gross Margin | 13.3% | 16.6% | 16.8% | 14.0% | 13.3% |
| Research & Development | 10.1M | 10.4M | 12.54M | 16.52M | 18.32M |
| Selling, General & Admin | 131.77M | 132.79M | 134.94M | 191.79M | 203.27M |
| Operating Expenses | 152.37M | 154.91M | 157.12M | 224.62M | 221.59M |
| Depreciation & Amortization | 47M | 41.9M | 42.43M | 60.7M | 67.11M |
| EBITDA | 130.26M | 274.05M | 170.97M | 105.4M | 94.52M |
| EBITDA Margin | 7.3% | 12.6% | 9.4% | 5.7% | 5.2% |
| Operating Income | 85.18M | 205.8M | 148.73M | 33.18M | 20.76M |
| Operating Margin | 4.8% | 9.5% | 8.2% | 1.8% | 1.1% |
| Interest Income | 0 | 2.35M | 0 | 11.02M | 10.7M |
| Interest Expense | 32.22M | 32.15M | 18.79M | 36.43M | 38.71M |
| Other Income / Expenses | (34.14M) | (3.45M) | (38.98M) | (24.91M) | (32.06M) |
| Income Before Tax | 51.04M | 202.35M | 109.75M | 8.27M | (11.3M) |
| Pre-Tax Margin | 2.9% | 9.3% | 6.0% | 0.4% | -0.6% |
| Income Tax Expense | 1.15M | 23.17M | 26.04M | 11.86M | 49.89M |
| Net Income | 49.59M | 176.3M | 78.76M | (5.56M) | (63.49M) |
| Net Margin | 2.8% | 8.1% | 4.3% | -0.3% | -3.5% |
| EPS (Basic) | 0.80 | 2.80 | 1.26 | (0.08) | (1.00) |
| EPS (Diluted) | 0.79 | 2.77 | 1.25 | (0.08) | (1.00) |
| Weighted Avg Shares | 62.1M | 63.04M | 62.45M | 68.66M | 63.49M |
| Weighted Avg Shares (Diluted) | 62.69M | 63.69M | 62.96M | 68.66M | 63.71M |
Titan International, Inc.
NYSE:TWI
Intrinsic Alpha fair value
Locked
Current Price
$4.39
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.